{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:44Z","timestamp":1791357224195,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jagp.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T20:31:27Z","timestamp":1489005087000},"page":"791-802","source":"Crossref","is-referenced-by-count":69,"title":["Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials"],"prefix":"10.1016","volume":"25","author":[{"given":"W. Joseph","family":"Herring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane B.","family":"Snavely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Hutzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Matzura-Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Benca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2017.03.004_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/sleep\/18.6.425","article-title":"Sleep complaints among elderly persons: an epidemiologic study of three communities","volume":"18","author":"Foley","year":"1995","journal-title":"Sleep"},{"issue":"7 suppl","key":"10.1016\/j.jagp.2017.03.004_bib0015","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1111\/j.1532-5415.2005.53392.x","article-title":"Prevalence and comorbidity of insomnia and effect on functioning in elderly populations","volume":"53","author":"Ancoli-Israel","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 2","key":"10.1016\/j.jagp.2017.03.004_bib0020","first-page":"S347","article-title":"Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I","volume":"22","author":"Ancoli-Israel","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.jagp.2017.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/sleep\/27.7.1255","article-title":"Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan","volume":"27","author":"Ohayon","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.jagp.2017.03.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2007.08.007","article-title":"Aging-related sleep changes","volume":"24","author":"Espiritu","year":"2008","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jagp.2017.03.004_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1532-5415.2009.02220.x","article-title":"Evidence-based recommendations for the assessment and management of sleep disorders in older persons","volume":"57","author":"Bloom","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2017.03.004_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1880-6805-31-5","article-title":"Daily rhythms of the sleep-wake cycle","volume":"31","author":"Waterhouse","year":"2012","journal-title":"J Physiol Anthropol"},{"key":"10.1016\/j.jagp.2017.03.004_bib0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cger.2014.04.007","article-title":"Sleep in older adults: normative changes, sleep disorders, and treatment options","volume":"30","author":"Gooneratne","year":"2014","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jagp.2017.03.004_bib0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","article-title":"Insomnia pharmacotherapy","volume":"9","author":"Roehrs","year":"2012","journal-title":"Neurother"},{"key":"10.1016\/j.jagp.2017.03.004_bib0055","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2017.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2017.03.004_bib0065","doi-asserted-by":"crossref","first-page":"e8343","DOI":"10.1136\/bmj.e8343","article-title":"Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration","volume":"345","author":"Huedo-Medina","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jagp.2017.03.004_bib0070","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.2174\/13816128113196660695","article-title":"Medications affecting functional status in older persons","volume":"20","author":"Corsonello","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jagp.2017.03.004_bib0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17512433.2014.864949","article-title":"Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem?","volume":"7","author":"Levy","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jagp.2017.03.004_bib0080","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2017.03.004_bib0085","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1021\/jm100541c","article-title":"Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia","volume":"53","author":"Cox","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.jagp.2017.03.004_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/01677063.2011.566953","article-title":"Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist","volume":"25","author":"Winrow","year":"2011","journal-title":"J Neurogenet"},{"key":"10.1016\/j.jagp.2017.03.004_bib0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-012-0036-8","article-title":"Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status","volume":"27","author":"Mieda","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jagp.2017.03.004_bib0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bph.12261","article-title":"Discovery and development of orexin receptor antagonists as therapeutics for insomnia","volume":"171","author":"Winrow","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jagp.2017.03.004_bib0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2017.03.004_bib0110","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","article-title":"Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"13","author":"Michelson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2017.03.004_bib0115","article-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.jagp.2017.03.004_bib0120","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2017.03.004_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-0327(90)90009-W","article-title":"The benzodiazepine withdrawal symptom questionnaire","volume":"19","author":"Tyrer","year":"1990","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2017.03.004_bib0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2307\/2530872","article-title":"Two-stage analysis based on a mixed model: large-sample asymptotic theory and small-sample simulation results","volume":"41","author":"Giesbrecht","year":"1985","journal-title":"Biometrics"},{"key":"10.1016\/j.jagp.2017.03.004_bib0135","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00213-016-4375-x","article-title":"On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30\u2009mg in healthy elderly","volume":"233","author":"Vermeeren","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jagp.2017.03.004_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2017.03.004_bib0145","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jagp.2017.03.004_bib0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5664\/jcsm.5382","article-title":"Effects of suvorexant, an orexin receptor antagonist, on respiration during sleep in patients with obstructive sleep apnea","volume":"12","author":"Sun","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.jagp.2017.03.004_bib0155","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.rmed.2014.12.010","article-title":"Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease","volume":"109","author":"Sun","year":"2015","journal-title":"Respir Med"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748117302531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748117302531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T14:52:54Z","timestamp":1657378374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748117302531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1064748117302531"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2017.03.004","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}